| Sarcomatoid Carcinoma studied in …STUDIED_INderived37 of 37show fewer |
|---|
| → studied in | NCT03866382Phase 2 · recruiting Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors · condition mapped ONTOLOGY_EXACT · 37 trials mapped (22 active) | — | — | Invasive Bladder Sarcomatoid Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07005297not yet recruiting Clinical Genetics Branch Eligibility Screening Survey · condition mapped ONTOLOGY_EXACT · 37 trials mapped (22 active) | — | — | Pulmonary Blastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02734537Phase 2 · recruiting Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery · condition mapped ALIAS · 37 trials mapped (22 active) | — | — | Laryngeal Spindle Cell Squamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02812420early Phase 1 · active not recruiting Durvalumab and Tremelimumab in Treating Patients With Muscle-Invasive, High-Risk Urothelial Cancer That Cannot Be Treated With Cisplatin-Based Therapy Before Surgery · condition mapped ALIAS · 37 trials mapped (22 active) | — | — | Invasive Bladder Sarcomatoid Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02496208Phase 1 · active not recruiting Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors · condition mapped ONTOLOGY_EXACT · 37 trials mapped (22 active) | — | — | Invasive Bladder Sarcomatoid Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06568172Phase 3 · suspended Testing the Addition of an Immunotherapy Drug, Cemiplimab (REGN2810), Plus Surgery to the Usual Surgery Alone for Treating Advanced Skin Cancer · condition mapped CURATED_BROADER · 37 trials mapped (22 active) | — | — | Skin Spindle Cell Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03793166Phase 3 · active not recruiting Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study · condition mapped ONTOLOGY_EXACT · 37 trials mapped (22 active) | — | — | Sarcomatoid Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03055013Phase 3 · active not recruiting Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy · condition mapped ONTOLOGY_EXACT · 37 trials mapped (22 active) | — | — | Sarcomatoid Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06866262Phase 1/Phase 2 · recruiting Inulin Gel in Combination With Ipilimumab and Nivolumab for the Treatment of Metastatic or Locally Advanced Kidney Cell Cancer, ICON Trial · condition mapped CURATED_BROADER · 37 trials mapped (22 active) | — | — | Sarcomatoid Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06049576Phase 1 · active not recruiting Nivolumab and Ipilimumab With and Without Camu Camu for the Treatment of Patients With Metastatic Renal Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 37 trials mapped (22 active) | — | — | Sarcomatoid Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03541902Phase 2 · active not recruiting Cabozantinib or Sunitinib Malate in Treating Participants With Metastatic Variant Histology Renal Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 37 trials mapped (22 active) | — | — | Sarcomatoid Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03744793Phase 2 · active not recruiting Pemetrexed and Avelumab in Treating Patients With MTAP-Deficient Metastatic Urothelial Cancer · condition mapped ALIAS · 37 trials mapped (22 active) | — | — | Invasive Bladder Sarcomatoid Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07128680Phase 1 · recruiting Immunotherapy (Nivolumab and Ipilimumab) With and Without a Live Biotherapeutic Product (EXL01) for the Treatment of Metastatic Renal Cell Cancer · condition mapped CURATED_BROADER · 37 trials mapped (22 active) | — | — | Sarcomatoid Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02834013Phase 2 · active not recruiting Nivolumab and Ipilimumab in Treating Patients With Rare Tumors · condition mapped ONTOLOGY_EXACT · 37 trials mapped (22 active) | — | — | Lung Sarcomatoid Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06447103Phase 2 · recruiting An Investigational Scan (89Zr-DFO-GmAb PET/CT) Compared to Contrast-Enhanced CT for the Detection of Recurrent Clear Cell Renal Cell Cancer After Surgery Comparing Carbonic Anhydrase IX (CAIX) PET CT to Conventional PET CT for Post-Op Staging in Kidney Cancer · condition mapped ONTOLOGY_EXACT · 37 trials mapped (22 active) | — | — | Sarcomatoid Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07037004Phase 2 · recruiting Adding a Live Biotherapeutic Product (CBM588) to Pembrolizumab for the Treatment of Renal Cell Cancer After Surgery · condition mapped ONTOLOGY_EXACT · 37 trials mapped (22 active) | — | — | Sarcomatoid Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05154994Phase 1 · active not recruiting Tremelimumab + Durvalumab(MEDI4736)+ Belinostat in Urothelial Carcinoma · condition mapped ALIAS · 37 trials mapped (22 active) | — | — | Invasive Sarcomatoid Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05808608Phase 1/Phase 2 · active not recruiting A Study of AK104 Plus Axitinib in Advanced/Metastatic Special Pathological Subtypes of Renal Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 37 trials mapped (22 active) | — | — | Sarcomatoid Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05122546Phase 1 · active not recruiting CBM588 in Combination With Nivolumab and Cabozantinib for the Treatment of Advanced or Metastatic Kidney Cancer · condition mapped CURATED_BROADER · 37 trials mapped (22 active) | — | — | Sarcomatoid Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07218692Phase 2 · not yet recruiting RP2 and Tivozanib for the Treatment of Metastatic Renal Cell Cancer After Progression on Immunotherapy · condition mapped CURATED_BROADER · 37 trials mapped (22 active) | — | — | Sarcomatoid Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04272034Phase 1 · terminated Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 37 trials mapped (22 active) | — | — | Sarcomatoid Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06683846Phase 2 · recruiting Ivonescimab in the Treatment of Multiple Advanced Tumors · condition mapped ONTOLOGY_EXACT · 37 trials mapped (22 active) | — | — | Sarcomatoid Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03685448Phase 2 · completed ANZUP - Non-clear Cell Post Immunotherapy CABozantinib (UNICAB) · condition mapped ONTOLOGY_EXACT · 37 trials mapped (22 active) | — | — | Sarcomatoid Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06950814recruiting Prognostic Impact of Adjuvant Therapy in Primary Hepatic Sarcomatoid Carcinoma · condition mapped ONTOLOGY_EXACT · 37 trials mapped (22 active) | — | — | Sarcomatoid Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02983279NA · completed Caloric Restriction Before Surgery in Treating Patients With Endometrial, Prostate, or Breast Cancer · condition mapped ALIAS · 37 trials mapped (22 active) | — | — | Prostate Acinar Sarcomatoid Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05337163completed A Multicenter Clinical Trial of Sputum DNA Testing for Lung Cancer in China · condition mapped ONTOLOGY_EXACT · 37 trials mapped (22 active) | — | — | Sarcomatoid Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01767636Phase 2 · completed Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer · condition mapped ONTOLOGY_EXACT · 37 trials mapped (22 active) | — | — | Sarcomatoid Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06399419Phase 1 · recruiting CBM588 Capsules in Combination With Nivolumab and Ipilimumab for the Treatment of Advanced Stage Kidney Cancer · condition mapped CURATED_BROADER · 37 trials mapped (22 active) | — | — | Sarcomatoid Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03912818Phase 2 · terminated Durvalumab and Standard Chemotherapy Before Surgery in Treating Patients With Variant Histology Bladder Cancer · condition mapped ALIAS · 37 trials mapped (22 active) | — | — | Invasive Bladder Sarcomatoid Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00068393Phase 2 · completed Doxorubicin and Gemcitabine in Treating Patients With Locally Recurrent or Metastatic Unresectable Renal Cell Carcinoma · condition mapped ALIAS · 37 trials mapped (22 active) | — | — | Sarcomatoid Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01664182Phase 2 · completed Trebananib With or Without Bevacizumab, Pazopanib Hydrochloride, Sorafenib Tosylate, or Sunitinib Malate in Treating Patients With Advanced Kidney Cancer · condition mapped CURATED_BROADER · 37 trials mapped (22 active) | — | — | Sarcomatoid Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05265793Phase 2 · unknown Camrelizumab Combined With Apatinib in the Treatment of Advanced Sarcomatoid Carcinoma or Carcinosarcoma · condition mapped ONTOLOGY_EXACT · 37 trials mapped (22 active) | — | — | Sarcomatoid Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03177239Phase 2 · unknown Phase II Sequential Treatment Trial of Single Agent Nivolumab, Then Combination Ipilimumab + Nivolumab in Metastatic or Unresectable Non-Clear Cell Renal Cell Carcinoma (ANZUP1602) · condition mapped ONTOLOGY_EXACT · 37 trials mapped (22 active) | — | — | Sarcomatoid Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02897479Phase 2 · unknown A Phase II Study of HMPL-504 in Lung Sarcomatoid Carcinoma and Other Non-small Cell Lung Cancer · condition mapped ONTOLOGY_EXACT · 37 trials mapped (22 active) | — | — | Lung Sarcomatoid Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02029690Phase 1 · terminated Ph 1 Study in Subjects With Tumors Requiring Arginine to Assess ADI-PEG 20 With Pemetrexed and Cisplatin · condition mapped ONTOLOGY_EXACT · 37 trials mapped (22 active) | — | — | Sarcomatoid Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02964351unknown microRNA Profiles Identification in Adeno Carcinoma Prostate Cancer · condition mapped ALIAS · 37 trials mapped (22 active) | — | — | Prostate Acinar Sarcomatoid Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00126503Phase 1/Phase 2 · completed Sorafenib Tosylate and Bevacizumab in Treating Patients With Advanced Kidney Cancer · condition mapped ONTOLOGY_EXACT · 37 trials mapped (22 active) | — | — | Sarcomatoid Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |